Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20241248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Zhe Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, School of Basic Medical Sciences, Chongqing Medical Univers…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Poly-ADP-Ribose Binding Proteins, Fanconi Anemia, Chromosomal Proteins, Non-Histone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chongqing Science Fund, Doctor Research Project of Chongqing, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) are susceptible to replication stress, which is a major contributor to HSC defects in Fanconi anemia (FA). Here, we report that HSCs relax the global chromatin by downregulating the expression of a chromatin architectural protein, DEK, in response to replication stress. DEK is abnormally accumulated in bone marrow (BM) CD34+ cells from patients with FA and in Fancd2-deficient HSCs. DEK haploinsufficiency promotes chromatin relaxation, replication stress relief, and function recovery of Fancd2-deficient HSCs. Furthermore, inhibition of DEK restores the proliferation of FA CD34+ cells in vitro and enhances their engraftment in vivo. Mechanistically, the activating transcription factor 2 (ATF2), specifically phosphorylated ATF2 at Thr69/71, was identified as a promoter of DEK transcription. Fancd2 deficiency results in p38 hyperphosphorylation, which in turn phosphorylates ATF2 at Thr69/71, leading to DEK accumulation in HSCs. In conclusion, our findings establish a functional link between chromatin relaxation and replication stress tolerance in HSCs and highlight DEK as a target for FA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
- School of Basic Medical Sciences, Chongqing Medical University , Chongqing, China.
- Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University , Chongqing, China.
- School of Medicine, Guizhou University , Guiyang, China.
- Department of Hematology and Oncology, Children's Hospital, Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Hematology and Microenvironment , Chongqing, China.
ORCID-Profile: Zhe Chen, Feng Wu, Yan Li, Lei Li, Yufei Lei, Siwei Gao, Tao Chen, Yuxin Xie, Jianwen Xiao, Hanqing Zeng, Jianchuan Deng, Xueya Zhao, Yu Hou
Förderung
- Chongqing Science Fund
- Doctor Research Project of Chongqing
- National Natural Science Foundation of China
- Chongqing Medical University
- Chongqing Municipal Education Commission
Zitieren
APA
Chen, Z., Wu, F., Li, Y., Li, L., Lei, Y., Gao, S., Chen, T., Xie, Y., Xiao, J., Zeng, H., Deng, J., Zhao, X., & Hou, Y. (2025). Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20241248
Vancouver
Chen Z, Wu F, Li Y, Li L, Lei Y, Gao S, et al. Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20241248
BibTeX
@article{Chen2025,
author = {Chen, Zhe and Wu, Feng and Li, Yan and Li, Lei and Lei, Yufei and Gao, Siwei and Chen, Tao and Xie, Yuxin and Xiao, Jianwen and Zeng, Hanqing and Deng, Jianchuan and Zhao, Xueya and Hou, Yu},
title = {Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20241248}
}
EUVIMED